SELB - Selecta merges with Cartesian Therapeutics in all-stock deal
2023-11-13 08:41:26 ET
More on Selecta Biosciences
- Selecta Biosciences GAAP EPS of -$0.07 beats by $0.01, revenue of $5.2M misses by $5.89M
- Seeking Alpha’s Quant Rating on Selecta Biosciences
- Historical earnings data for Selecta Biosciences
- Financial information for Selecta Biosciences
For further details see:
Selecta merges with Cartesian Therapeutics in all-stock deal